Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Low-Protein Diet Induces IRE1α-Dependent Anticancer Immunosurveillance.

Rubio-Patiño C, Bossowski JP, De Donatis GM, Mondragón L, Villa E, Aira LE, Chiche J, Mhaidly R, Lebeaupin C, Marchetti S, Voutetakis K, Chatziioannou A, Castelli FA, Lamourette P, Chu-Van E, Fenaille F, Avril T, Passeron T, Patterson JB, Verhoeyen E, Bailly-Maitre B, Chevet E, Ricci JE.

Cell Metab. 2018 Apr 3;27(4):828-842.e7. doi: 10.1016/j.cmet.2018.02.009.

PMID:
29551590
2.

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.

Zhao N, Cao J, Xu L, Tang Q, Dobrolecki LE, Lv X, Talukdar M, Lu Y, Wang X, Hu DZ, Shi Q, Xiang Y, Wang Y, Liu X, Bu W, Jiang Y, Li M, Gong Y, Sun Z, Ying H, Yuan B, Lin X, Feng XH, Hartig SM, Li F, Shen H, Chen Y, Han L, Zeng Q, Patterson JB, Kaipparettu BA, Putluri N, Sicheri F, Rosen JM, Lewis MT, Chen X.

J Clin Invest. 2018 Apr 2;128(4):1283-1299. doi: 10.1172/JCI95873. Epub 2018 Feb 26.

3.

Infliction of proteotoxic stresses by impairment of the unfolded protein response or proteasomal inhibition as a therapeutic strategy for mast cell leukemia.

Wilhelm T, Bick F, Peters K, Mohta V, Tirosh B, Patterson JB, Kharabi-Masouleh B, Huber M.

Oncotarget. 2017 Dec 17;9(3):2984-3000. doi: 10.18632/oncotarget.23354. eCollection 2018 Jan 9.

4.

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E.

EMBO Mol Med. 2018 Mar;10(3). pii: e7929. doi: 10.15252/emmm.201707929.

5.

Endoplasmic reticulum stress-mediated induction of SESTRIN 2 potentiates cell survival.

Saveljeva S, Cleary P, Mnich K, Ayo A, Pakos-Zebrucka K, Patterson JB, Logue SE, Samali A.

Oncotarget. 2016 Mar 15;7(11):12254-66. doi: 10.18632/oncotarget.7601.

6.

Deregulated expression of the HSP40 family members Auxilin-1 and -2 is indicative of proteostasis imbalance and predicts patient outcome in Ph(+) leukemia.

Vieri M, Geng H, Patterson JB, Panse J, Wilop S, Samali A, Chevet E, Kharabi Masouleh B.

Exp Hematol Oncol. 2016 Feb 9;5:5. doi: 10.1186/s40164-016-0034-5. eCollection 2015.

7.

Adaptation of the secretory pathway in cancer through IRE1 signaling.

Lhomond S, Pallares N, Barroso K, Schmit K, Dejeans N, Fazli H, Taouji S, Patterson JB, Chevet E.

Methods Mol Biol. 2015;1292:177-94. doi: 10.1007/978-1-4939-2522-3_13.

PMID:
25804756
8.

Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors.

Sanches M, Duffy NM, Talukdar M, Thevakumaran N, Chiovitti D, Canny MD, Lee K, Kurinov I, Uehling D, Al-awar R, Poda G, Prakesch M, Wilson B, Tam V, Schweitzer C, Toro A, Lucas JL, Vuga D, Lehmann L, Durocher D, Zeng Q, Patterson JB, Sicheri F.

Nat Commun. 2014 Aug 28;5:4202. doi: 10.1038/ncomms5202.

9.

Modulation of intracellular calcium homeostasis blocks autophagosome formation.

Engedal N, Torgersen ML, Guldvik IJ, Barfeld SJ, Bakula D, Sætre F, Hagen LK, Patterson JB, Proikas-Cezanne T, Seglen PO, Simonsen A, Mills IG.

Autophagy. 2013 Oct;9(10):1475-90. doi: 10.4161/auto.25900. Epub 2013 Aug 13.

PMID:
23970164
10.

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.

Mimura N, Fulciniti M, Gorgun G, Tai YT, Cirstea D, Santo L, Hu Y, Fabre C, Minami J, Ohguchi H, Kiziltepe T, Ikeda H, Kawano Y, French M, Blumenthal M, Tam V, Kertesz NL, Malyankar UM, Hokenson M, Pham T, Zeng Q, Patterson JB, Richardson PG, Munshi NC, Anderson KC.

Blood. 2012 Jun 14;119(24):5772-81. doi: 10.1182/blood-2011-07-366633. Epub 2012 Apr 26.

11.

Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease.

Volkmann K, Lucas JL, Vuga D, Wang X, Brumm D, Stiles C, Kriebel D, Der-Sarkissian A, Krishnan K, Schweitzer C, Liu Z, Malyankar UM, Chiovitti D, Canny M, Durocher D, Sicheri F, Patterson JB.

J Biol Chem. 2011 Apr 8;286(14):12743-55. doi: 10.1074/jbc.M110.199737. Epub 2011 Feb 8.

12.

Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.

Koizumi T, Fitzgerald PJ, Honda Y, Ellis SG, Kent K, Martin SL, Brown CL, Masud AR, Patterson JB, Greenberg J, Friedman M, Uchida T, Stone GW.

Cardiovasc Revasc Med. 2010 Jul-Sep;11(3):140-8. doi: 10.1016/j.carrev.2009.07.004.

PMID:
20599163
13.

Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells.

Virrey JJ, Dong D, Stiles C, Patterson JB, Pen L, Ni M, Schönthal AH, Chen TC, Hofman FM, Lee AS.

Mol Cancer Res. 2008 Aug;6(8):1268-75. doi: 10.1158/1541-7786.MCR-08-0060.

14.

Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.

Dong D, Ko B, Baumeister P, Swenson S, Costa F, Markland F, Stiles C, Patterson JB, Bates SE, Lee AS.

Cancer Res. 2005 Jul 1;65(13):5785-91.

15.

Choice: ethical and legal rehabilitation challenges.

Patterson JB, Patrick A, Parker RM.

Rehabil Couns Bull. 2000 Summer;43(4):203-8.

PMID:
15714701
16.

Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir.

Stevens RC, Rapaport S, Maroldo-Connelly L, Patterson JB, Bertz R.

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):650-1. No abstract available.

PMID:
12902812
17.

Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease.

Patterson JB, Cornu TI, Redwine J, Dales S, Lewicki H, Holz A, Thomas D, Billeter MA, Oldstone MB.

Virology. 2001 Dec 20;291(2):215-25.

18.

Disease model: dissecting the pathogenesis of the measles virus.

Patterson JB, Manchester M, Oldstone MB.

Trends Mol Med. 2001 Feb;7(2):85-8. Review. Erratum in: Trends Mol Med 2001 May;7(5):231.

PMID:
11286761
19.

V and C proteins of measles virus function as virulence factors in vivo.

Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB.

Virology. 2000 Feb 1;267(1):80-9.

20.

Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction.

Patterson JB, Scheiflinger F, Manchester M, Yilma T, Oldstone MB.

Virology. 1999 Mar 30;256(1):142-51.

21.

Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.

Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, Atkinson JP, Oldstone MB.

Virology. 1997 Jun 23;233(1):174-84.

23.

Stump the experts. Case. Granular-cell tumor.

Skidmore RA, Groben P, Patterson JB.

Dermatol Surg. 1995 Nov;21(11):925, 997-8. Review. No abstract available.

PMID:
7582829
25.
26.

Chemotactic peptide stimulation of leukotrienes from healthy and inflamed rabbit colons.

Zipser RD, Patterson JB, Leduc LE.

J Pharmacol Exp Ther. 1987 Apr;241(1):218-22.

PMID:
3572785
27.

Hypersensitive prostaglandin and thromboxane response to hormones in rabbit colitis.

Zipser RD, Patterson JB, Kao HW, Hauser CJ, Locke R.

Am J Physiol. 1985 Oct;249(4 Pt 1):G457-63.

PMID:
4050996
28.

Variables related to acceptance of disability in persons with spinal cord injuries.

Woodrich F, Patterson JB.

J Rehabil. 1983 Jul-Sep;49(3):26-30. No abstract available.

PMID:
6226783
29.

Pemphigus vulgaris of the esophagus.

Wood DR, Patterson JB, Orlando RC.

Ann Intern Med. 1982 Feb;96(2):189-91. No abstract available.

PMID:
7036813
30.

A simple method for protecting breast implants during insertion.

Lavine DM, Patterson JB.

Ann Plast Surg. 1981 Nov;7(5):418-9. No abstract available.

PMID:
7332209
31.

Effect of mercuric and silver ions on cesium sulfate equilibrium buoyant densities of synthetic polydeoxyribonucleotides.

Lieberman MW, Harvan DJ, Amacher DE, Patterson JB.

Biochim Biophys Acta. 1976 Mar 17;425(3):265-77.

PMID:
1259972
32.

Chemical dosimetry in somatic cells and its utility to mutagenesis.

Patterson JB.

Environ Health Perspect. 1973 Dec;6:195-9. No abstract available.

33.

Characterization of sea urchin ribosomal satellite deoxyribonucleic acid.

Patterson JB, Stafford DW.

Biochemistry. 1971 Jul 6;10(14):2775-9. No abstract available.

PMID:
4326881
34.

Sea urchin satellite deoxyribonucleic acid. Its large-scale isolation and hybridization with homologous ribosomal ribonucleic acid.

Patterson JB, Stafford DW.

Biochemistry. 1970 Mar 3;9(5):1278-83. No abstract available.

PMID:
4907415
35.

The role of wheat germ oil concentrate in prepartum care.

PATTERSON JB, SILBERNAGEL WM.

J Int Coll Surg. 1961 Mar;35:335-41. No abstract available.

PMID:
13733366
36.

One in a million. Homografting between identical twins: a case report.

PATTERSON JB.

Plast Reconstr Surg Transplant Bull. 1960 May;25:510-6. No abstract available.

PMID:
14430919
37.

Congenital orbital deformity: a case report.

PATTERSON JB.

Plast Reconstr Surg Transplant Bull. 1958 Sep;22(3):271-4. No abstract available.

PMID:
13590981
38.

Abruptio placentae.

SILBERNAGEL WM, PATTERSON JB.

J Int Coll Surg. 1957 Sep;28(3 Pt 1):321-5. No abstract available.

PMID:
13475892
39.

Plastic surgery in the correction of congenital deformities in children.

PATTERSON JB.

Tex State J Med. 1955 Dec;51(12):804-8. No abstract available.

PMID:
13274357
40.

Carcinoma of Moll's glands with extramammary Paget's disease of the eyelid.

WHORTON CM, PATTERSON JB.

Cancer. 1955 Sep-Oct;8(5):1009-15. No abstract available.

PMID:
13261058
41.

An aid in the avoidance of fetal loss and in the prevention of maternal complications.

SILBERNAGEL WM, PATTERSON JB.

J Int Coll Surg. 1955 Jun;23(6 Section 1):719-23. No abstract available.

PMID:
14381647
42.

Eventration in the newborn.

FUSCO EM, PATTERSON JB, MCCALL EW.

Ohio State Med J. 1952 Dec;48(12):1112-4. No abstract available.

PMID:
13003118
43.

Wheat germ oil concentrate as an acid in the reduction of pregnancy complications.

SILBERNAGEL WM, PATTERSON JB.

Ohio State Med J. 1951 Jun;47(6):533-5. No abstract available.

PMID:
14833734
44.

Oral administration of wheat germ oil concentrate as an aid in the reduction of pregnancy complications.

SILBERNAGEL WM, PATTERSON JB.

J Clin Endocrinol Metab. 1950 Jul;10(7):832. No abstract available.

PMID:
15436622
45.

Prophylactic administration of wheat germ oil concentrate in pregnancy; a clinical analysis.

SILBERNAGEL WM, PATTERSON JB.

Ohio State Med J. 1949 Feb;45(2):141-3. No abstract available.

PMID:
18108110
46.

The preparation of granulating wounds for grafting; a method.

MILLS JT, PATTERSON JB, HOUSE RE.

Plast Reconstr Surg (1946). 1948 May;3(3):245-61. No abstract available.

PMID:
18865409
47.

Reconstruction of the thumb.

WICKSTROM OW, PATTERSON JB.

U S Nav Med Bull. 1947 Sep-Oct;47(5):880-4. No abstract available.

PMID:
20265502
48.

The combined use of multiple excision, the Z-plastic and sliding flaps in the correction of certain congenital and acquired anomalies.

MILLS JT, PATTERSON JB.

Plast Reconstr Surg (1946). 1947 May;2(3):249-59. No abstract available.

PMID:
20242224
49.

Field trials of copper fungicides for the control of potato blight; spray retention.

LARGE EC, BEER WJ, PATTERSON JB.

Ann Appl Biol. 1946 Feb;33(1):54-63. No abstract available.

PMID:
20997937

Supplemental Content

Loading ...
Support Center